Home > Income Statement > INDOCO REMEDIES

INDOCO REMEDIES
Revenue

    Back to Income Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹1,817 Cr₹1,669 Cr₹1,541 Cr₹1,242 Cr₹1,107 Cr

What is the latest Revenue of INDOCO REMEDIES ?

The latest Revenue ratio of INDOCO REMEDIES is ₹1,817 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹1,817 Cr
Mar2023₹1,669 Cr
Mar2022₹1,541 Cr
Mar2021₹1,242 Cr
Mar2020₹1,107 Cr

How is Revenue of INDOCO REMEDIES Trending?

Years Revenue % Change
Mar2024 ₹1,817 Cr
8.91
Mar2023 ₹1,669 Cr
8.30
Mar2022 ₹1,541 Cr
24.10
Mar2021 ₹1,242 Cr
12.19
Mar2020 ₹1,107 Cr -

Compare Revenue of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,627.2 Cr -2.3% -15.9% -10.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,115.0 Cr 3.5% -3.4% -5.8% Stock Analytics
DIVIS LABORATORIES ₹162,735.0 Cr 3.7% -10.2% 25.6% Stock Analytics
CIPLA ₹126,313.0 Cr 5.3% 6.1% -1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,592.0 Cr 1.4% 4.6% 7.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,095.0 Cr 3.9% 0% -9.9% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-2.3%

-15.9%

-10.2%

SENSEX

-0%

-2.4%

1.2%


You may also like the below Video Courses